sábado, 3 de septiembre de 2022

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period - The Lancet Rheumatology

SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period - The Lancet Rheumatology

No hay comentarios:

Publicar un comentario